[Relationship between TIMP-3 expression and promoter methylation of TIMP-3 gene in hepatocellular carcinoma]
- PMID: 12882688
[Relationship between TIMP-3 expression and promoter methylation of TIMP-3 gene in hepatocellular carcinoma]
Abstract
Objective: To investigate further the possible mechanism of carcinogenesis and portal invasion of hepatocellular carcinoma (HCC).
Methods: Samples of the primary tumors, cancer cells emboli in the portal veins and normal liver tissues adjacent to the tumor were collected from 20 cases of primary HCC. Expression of TIMP-3 (tissue inhibitor of metalloproteinases-3) protein was detected using Western blot. Expression of TIMP-3 mRNA was detected by RT-PCR. Methylation of TIMP-3 gene promoter was detected using methylation-specific PCR (MSP).
Results: Expression of TIMP-3 protein and mRNA were obtained in all of the normal liver tissues adjacent to tumor. However, loss of TIMP-3 protein expression was found in 5 and 36 cases respectively in the primary tumors and tumor cell emboli in portal veins. Expression of TIMP-3 protein and mRNA in primary tumors and tumor emboli were significantly lower than that in the normal liver tissues. Promoter methylation of TIMP-3 gene could be detected in primary tumors (7 cases) and cancerous emboli (9 cases) in HCC, while no methylation found in normal liver tissues. In all the HCC cases with promoter gene methylation including primary tumors and cancerous emboli in portal veins, 13 cases showed complete loss and 6 cases showed low expression of TIMP-3 protein and mRNA. Promoter methylation of TIMP-3 was noticed not related with the histological grading of HCC.
Conclusions: There is a close relationship between loss or low expressions of TIMP-3 and carcinogenesis and portal invasion of HCC. The loss and low expression of TIMP-3 gene and protein were caused by methylation of the gene promoter.
Similar articles
-
Methylation of promoter and expression silencing of GPX3 gene in hepatocellular carcinoma tissue.Clin Res Hepatol Gastroenterol. 2015 Apr;39(2):198-204. doi: 10.1016/j.clinre.2014.09.003. Epub 2014 Oct 13. Clin Res Hepatol Gastroenterol. 2015. PMID: 25445749
-
Expression and inhibitory role of TIMP-3 in hepatocellular carcinoma.Oncol Rep. 2016 Jul;36(1):494-502. doi: 10.3892/or.2016.4818. Epub 2016 May 18. Oncol Rep. 2016. PMID: 27222429
-
Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.Oncogene. 2000 Nov 2;19(46):5298-302. doi: 10.1038/sj.onc.1203898. Oncogene. 2000. PMID: 11077447
-
Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma.World J Gastroenterol. 2015 Apr 7;21(13):3960-9. doi: 10.3748/wjg.v21.i13.3960. World J Gastroenterol. 2015. PMID: 25852282 Free PMC article.
-
[Correlation between androgen receptor expression and hepatitis B virus X protein and its clinical significance in hepatocellular carcinoma].Zhonghua Zhong Liu Za Zhi. 2013 Apr;35(4):282-7. doi: 10.3760/cma.j.issn.0253-3766.2013.04.009. Zhonghua Zhong Liu Za Zhi. 2013. PMID: 23985257 Chinese.
Cited by
-
Epigenetic mechanisms involved in the pathogenesis of hepatobiliary malignancies.Epigenomics. 2010 Apr 1;2(2):233-243. doi: 10.2217/epi.10.9. Epigenomics. 2010. PMID: 20556199 Free PMC article.
-
DNA methylation in hepatocellular carcinoma.World J Gastroenterol. 2008 Mar 21;14(11):1741-8. doi: 10.3748/wjg.14.1741. World J Gastroenterol. 2008. PMID: 18350605 Free PMC article. Review.
-
Tissue inhibitor of metalloproteinase-3 expression affects clinicopathological features and prognosis of aflatoxin B1-related hepatocellular carcinoma.World J Hepatol. 2024 Aug 27;16(8):1131-1144. doi: 10.4254/wjh.v16.i8.1131. World J Hepatol. 2024. PMID: 39221097 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous